search
Back to results

RAT and FES Effects on Upper Limb Motor Function in Subacute Stroke Patients

Primary Purpose

Motor Function

Status
Not yet recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Functional Electrical Stimulation
Hand Robotic-Assisted Therapy
Sponsored by
Neuron, Spain
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Motor Function focused on measuring Functional Electrical Stimulation, Stroke, Motor function, Upper limb, Hand

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Acquired brain damage (caused by stroke or TBI) with less than one year of evolution.
  • Upper limb impairment and a score on the FMA-UE scale >11 and <55.
  • To present a stable clinical condition.
  • Have no other neurological or disabling pathology or previous dependence.
  • Agree to participate in the study and sign the informed consent form.

Exclusion Criteria:

  • Having suffered epileptic seizures within 6 months prior to the start of the study.
  • Pain >5 on the Visual Analogue Scale (VAS) or the Verbal Numerical Scale (VNS).
  • Score <21 points on the Mini-Mental State Examination scale.
  • Failure to sign the informed consent form.
  • Occurrence of adverse events during or after the sessions.

Sites / Locations

  • Neuron Mercedes

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

FES + conventional treatment

Conventional treatment

Arm Description

60 minutes per session, 5 sessions per week with 30 minutes of task-specific training using Functional Electrical Stimulation applyed by Fesia Grasp device and 30 minutes of Robotic-Assisted Therapy using Amadeo robot for hand rehabilitation

60 minutes per session, 5 sessions per week with 30 minutes of task-specific training and 30 minutes of Robotic-Assisted Therapy using Amadeo robot for hand rehabilitation

Outcomes

Primary Outcome Measures

Upper limb motor function
the ability to learn or demonstrate the ability to acquire, maintain, modify and control voluntary postures and movement patterns with a goal framed motor behaviour. It will be measured wit the Action Research Arm Test (ARAT). This test asses the motor dexterity of the patient by 4 subtest based on functional movements (grasping, holding, clamping and gross movement

Secondary Outcome Measures

Manual grip strength
strength is the ability of a muscle or group of muscles to generate tension during maximum dynamic or static effort in relation to the demands placed upon it. In this way, the capacity of the flexor muscles of wrist and finguers will be measured using a manual dynamometer
Pinch strength
strength is the ability of a muscle or group of muscles to generate tension during maximum dynamic or static effort in relation to the demands placed upon it. In this way, the capacity of the flexor muscles of finguers will be measured using a pinch dynamometer
Quality of life measured with CAVIDACE questionnaire (Evaluación de la Calidad de Vida de personas con Daño Cerebral)
multidimensional phenomenon composed of 8 domains: emotional well-being, physical well-being, material well-being, self-determination, interpersonal relationships, social inclusion, personal development and individual rights. CAVIDACE questionnaire will be used to asses quality of life.The scale score ranges from 0 to 120, with higher scores corresponding to a higher quality of life.
Functional Independence
Functional independence refers to the person's ability to carry out functional activities of daily living without the assistance of others. The FIM-FAM test will be used to asses the functional independence in this population

Full Information

First Posted
October 4, 2022
Last Updated
March 14, 2023
Sponsor
Neuron, Spain
Collaborators
University of Castilla-La Mancha
search

1. Study Identification

Unique Protocol Identification Number
NCT05570838
Brief Title
RAT and FES Effects on Upper Limb Motor Function in Subacute Stroke Patients
Official Title
Effects of Robotic Assisted Therapy and Functional Electrical Stimulation on Upper Limb Motor Function in Subacute Stroke Patients
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
May 1, 2023 (Anticipated)
Primary Completion Date
December 1, 2024 (Anticipated)
Study Completion Date
July 1, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Neuron, Spain
Collaborators
University of Castilla-La Mancha

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Stroke is one of the leading causes of mortality worldwide and is the leading cause of disability. Currently, a large number of novel treatments are emerging with the aim of recovering the highest functionality and quality of life for these patients, including Robot Assisted Therapy (RAT) and functional electrostimulation (FES). The aim of this study is to observe the effect of FES with respect to conventional treatment and RAT for the improvement of motor function of the upper limb. For this purpose, a clinical trial will be carried out in which participants will be divided into two groups, a first group that will receive conventional treatment together with RAT and FES and a second group that will only receive conventional treatment combined with RAT. The hypothesis of the research group is that the group receiving conventional treatment together with RAT and FES will obtain greater improvements in motor function.
Detailed Description
On the first day, participants will be asked to sign the informed consent form and the inclusion and exclusion criteria will be reconfirmed. Subsequently, manual grip strength, terminal opposition grip strength, subterminal opposition grip strength, subterminal opposition grip strength, subterminal-lateral grip strength and tridigital grip strength will be assessed using a JAMAR dynamometer. After this, the CAVIDACE quality of life scale and the FIM-FAM functional independence scale will be completed. Finally, motor function assessment will be carried out with the ARAT. After the end of the treatment, the reassessment will be carried out and the initial assessments will be repeated. Subsequently, study participants will be followed up telematically, assessing quality of life using the CAVIDACE scale. Follow-up will be carried out 3 and 6 months after the end of treatment. The data collected will be stored in a database created for this purpose with the Microsoft Access programme. Subsequently, they will be analysed using the SPSS/PC statistical programme. An exploratory analysis of all the information collected will be carried out for descriptive purposes; qualitative variables will be analysed using percentages, while quantitative variables will be analysed using mean and standard deviation. In both cases, the confidence intervals will be 95%. After verifying whether the distribution of the data is normal or not, the hypothesis tests indicated in each case will be applied (χ2, Student's t, ANOVA, etc.). A significance level of 0.05 will be used for hypothesis testing. All analyses will be performed on an intention-to-treat basis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Motor Function
Keywords
Functional Electrical Stimulation, Stroke, Motor function, Upper limb, Hand

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
70 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
FES + conventional treatment
Arm Type
Experimental
Arm Description
60 minutes per session, 5 sessions per week with 30 minutes of task-specific training using Functional Electrical Stimulation applyed by Fesia Grasp device and 30 minutes of Robotic-Assisted Therapy using Amadeo robot for hand rehabilitation
Arm Title
Conventional treatment
Arm Type
Active Comparator
Arm Description
60 minutes per session, 5 sessions per week with 30 minutes of task-specific training and 30 minutes of Robotic-Assisted Therapy using Amadeo robot for hand rehabilitation
Intervention Type
Device
Intervention Name(s)
Functional Electrical Stimulation
Other Intervention Name(s)
FESIA grasp
Intervention Description
Functional Electrical Stimulation consist on applying a current on the damaged muscles when the patient is doing a task that requires them. 120 repetitions will be made on the 6 first sessions and 180 repetitions will be done after the sixth session
Intervention Type
Device
Intervention Name(s)
Hand Robotic-Assisted Therapy
Other Intervention Name(s)
AMADEO
Intervention Description
The hand Robotic-Assisted Therapy will be applyed using the AMADEO robot for hand rehabilitation by Tyromotion. The protocol that will be used consists on 200 repetitions on the active-assisted mode with flexion and extension of all the finguers and 50 repetitions on the active mode.
Primary Outcome Measure Information:
Title
Upper limb motor function
Description
the ability to learn or demonstrate the ability to acquire, maintain, modify and control voluntary postures and movement patterns with a goal framed motor behaviour. It will be measured wit the Action Research Arm Test (ARAT). This test asses the motor dexterity of the patient by 4 subtest based on functional movements (grasping, holding, clamping and gross movement
Time Frame
Change from Baseline in upper limb motor function at 6 weeks
Secondary Outcome Measure Information:
Title
Manual grip strength
Description
strength is the ability of a muscle or group of muscles to generate tension during maximum dynamic or static effort in relation to the demands placed upon it. In this way, the capacity of the flexor muscles of wrist and finguers will be measured using a manual dynamometer
Time Frame
Change from Baseline in manual grip strength at 6 weeks
Title
Pinch strength
Description
strength is the ability of a muscle or group of muscles to generate tension during maximum dynamic or static effort in relation to the demands placed upon it. In this way, the capacity of the flexor muscles of finguers will be measured using a pinch dynamometer
Time Frame
Change from Baseline in pinch strength at 6 weeks
Title
Quality of life measured with CAVIDACE questionnaire (Evaluación de la Calidad de Vida de personas con Daño Cerebral)
Description
multidimensional phenomenon composed of 8 domains: emotional well-being, physical well-being, material well-being, self-determination, interpersonal relationships, social inclusion, personal development and individual rights. CAVIDACE questionnaire will be used to asses quality of life.The scale score ranges from 0 to 120, with higher scores corresponding to a higher quality of life.
Time Frame
Change from Baseline in quality of life at 6 weeks 3 months and 6 months
Title
Functional Independence
Description
Functional independence refers to the person's ability to carry out functional activities of daily living without the assistance of others. The FIM-FAM test will be used to asses the functional independence in this population
Time Frame
Change from Baseline in functional independence at 6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Acquired brain damage (caused by stroke or TBI) with less than one year of evolution. Upper limb impairment and a score on the FMA-UE scale >11 and <55. To present a stable clinical condition. Have no other neurological or disabling pathology or previous dependence. Agree to participate in the study and sign the informed consent form. Exclusion Criteria: Having suffered epileptic seizures within 6 months prior to the start of the study. Pain >5 on the Visual Analogue Scale (VAS) or the Verbal Numerical Scale (VNS). Score <21 points on the Mini-Mental State Examination scale. Failure to sign the informed consent form. Occurrence of adverse events during or after the sessions.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lerín Calvo
Phone
620187457
Email
alfre_lerin@hotmail.com
Facility Information:
Facility Name
Neuron Mercedes
City
Madrid
ZIP/Postal Code
28022
Country
Spain
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mónica Grifol Domingo, PT
Phone
679664850
Email
mgrifol@neuronrehab.es
First Name & Middle Initial & Last Name & Degree
Mónica Grifol Domingo, PT

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
There is no plan for sharing IPD with other researchers

Learn more about this trial

RAT and FES Effects on Upper Limb Motor Function in Subacute Stroke Patients

We'll reach out to this number within 24 hrs